3 other companies on the FOBI longevity roster in Senolytics & Cellular Health
Seattle biotech using a non-viral lipid delivery platform to deliver gene-directed payloads that destroy senescent cells.
Utrecht spinout developing FOXO4-derived senolytic peptides to selectively destroy senescent cells in cancer and chronic disease.
1 more longevity companies in Senolytics & Cellular Health, plus side-by-side comparison links into the rest of the roster.
Already subscribed? Sign in →
San Francisco biotech developing drugs that activate iNKT immune cells to clear senescent cells from the body.